These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10347634)

  • 1. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive pulmonary disease].
    Bootsma GP; Van Weel C; Van Herwaarden CL
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):764. PubMed ID: 10347634
    [No Abstract]   [Full Text] [Related]  

  • 2. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
    van Schayck CP; Postma DS; Lammers JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease].
    Ringbaek TJ; Phanareth K; Lange P
    Ugeskr Laeger; 1996 Oct; 158(42):5957-62. PubMed ID: 8928288
    [No Abstract]   [Full Text] [Related]  

  • 4. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 5. [A long-acting adrenergic beta-sympathomimetics has its place in the treatment of many asthmatic patients].
    Stenius-Aarniala B
    Duodecim; 1999; 115(10):1081-3. PubMed ID: 11877847
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies.
    Skorodin MS
    Arch Intern Med; 1993 Apr; 153(7):814-28. PubMed ID: 8096690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of obstructive lung diseases].
    Kolle S; Mørkve O
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3268-71. PubMed ID: 9772813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathological and clinical studies on the use of beta-stimulating drugs].
    Tellini M; D'Ambrosio R
    Minerva Med; 1976 Mar; 67(15):999-1004. PubMed ID: 4754
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting beta-agonists in asthma.
    Agarwal A
    N Engl J Med; 2009 Jul; 361(2):208; author reply 209. PubMed ID: 19587350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy with beta adrenergic agents].
    Russi EW
    Schweiz Rundsch Med Prax; 1986 Jan; 75(5):94-7. PubMed ID: 2869565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug treatment of children with CARA].
    Van Nierop JC
    Tijdschr Kindergeneeskd; 1983 Dec; 51(6):207-17. PubMed ID: 6142544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indacaterol Novartis/skyePharma.
    Currie GP
    Curr Opin Investig Drugs; 2006 May; 7(5):457-63. PubMed ID: 16729723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-2 agonists in the therapy of obstructive airway diseases].
    Solèr M
    Praxis (Bern 1994); 1996 Sep; 85(38):1159-61. PubMed ID: 8927893
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting beta-2 agonists in asthma.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effectiveness of synergic therapy].
    Płusa T; Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment of chronic obstructive pulmonary disease].
    van Herwaarden CL; Dekhuijzen PN; van Schayck CP; van Weel C; Molema J
    Ned Tijdschr Geneeskd; 1996 Apr; 140(14):761-5. PubMed ID: 8668261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for a stepwise plan of long-term drug therapy in obstructive airway diseases].
    Geisler LS
    Dtsch Med Wochenschr; 1988 Oct; 113(41):1609-12. PubMed ID: 2901943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of berotek in patients with chronic obstructive lung diseases].
    Makel'skiĭ VV
    Klin Med (Mosk); 1975 Dec; 53(12):80-2. PubMed ID: 4646
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk versus benefit considerations for the beta(2)-agonists.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Asthma overmortality under beta-2-mimetics. Does it depend on the drug itself or on false use].
    Petro W
    MMW Fortschr Med; 2005 Mar; 147(10):16. PubMed ID: 15803777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.